Nuo Therapeutics Provides Corporate and Business Update
Broad equity incentive agreement established with Pacific Medical, Inc. including initial equity purchase Favorable initial progress on establishing substantive distribution...
News
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer
InFoods® IBS commercial launch and revenues expected before the close of calendar year 2022Mr. Carlson is an accomplished and performance-driven...
Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
ISELIN, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch...
ADVANCED MEDTECH EXPANDS LEADERSHIP TEAM WITH APPOINTMENT OF GREG MILLER AS CHIEF FINANCIAL OFFICER
Singapore, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Advanced MedTech Holdings appoints US-based CFO with more than 35 years’ expertise in...
Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference
SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...
Alignment Healthcare to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
ORANGE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced...
Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental Health
Latest NeuroStar innovation to simplify the motor threshold determination for cliniciansMALVERN, Pa., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc....
Galecto Announces Publication Supporting the Predictive Role of Galectin-3 on Overall Survival of NSCLC Patients in Peer-Reviewed Scientific Journal
BOSTON, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development...
Avricore Health Reports Second-Quarter 2022 Results
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased...
ALR Technologies Announces Update on the GluCurve Pet CGM Distribution and Commercialization
SINGAPORE, Aug. 29, 2022 (GLOBE NEWSWIRE) -- ALR Technologies SG Pte. Ltd (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes...
New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers
-- Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and...
Lowell Farms Inc. Announces Sale of Additional $2.2 Million of Convertible Debentures
SALINAS, Calif., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born innovator...
Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Press release Cambridge, MA U.S.A. (August 26, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage...
Adverum to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
REDWOOD CITY, Calif., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to...
RAMSAY SANTE :Update on the indicative offer received by Ramsay Health Care Limited
PRESS RELEASE Paris, August 26th 2022 Update on the indicative offer received by Ramsay Health Care Limited On 20 April...
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA
Negma Group has converted 200 convertible bonds in Oxurion resulting in a EUR 500,000 capital increase. This is part of...
P3 Health Partners Fireside Chat Hosted by LifeSci Advisors, LLC
Wednesday, August 31st @ 2pmETHENDERSON, Nev., Aug. 26, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ:...
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
Submission follows application for Omicron BA.1-adapted bivalent vaccine submitted in July If authorized, both Omicron BA.1-adapted and Omicron BA.4/5-adapted bivalent...
Active Health Foods, Inc. Ending Reg a Offering, Approves Substantial Reverse Split
Los Angeles, CA, Aug. 26, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) has terminated the previously announced...
Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer
Renown Pioneer in Regenerative Medicine to Lead Company’s Pipeline Development InitiativesSILVER SPRING, Md., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Aziyo...